Emblem Announces Changes to Board of Directors
TORONTO, Ontario, February 5, 2018 — Emblem Corp. (TSXV: EMC) (EMC.WT) (“Emblem” or the “Corporation“) announces that Mr. Gordon Fox, a director and founder of the Corporation, has tendered his resignation from the board of directors of the Corporation for personal reasons.
In light of Mr. Fox’s resignation, the board of directors has appointed Nick Dean, President and Chief Executive Officer of the Corporation, to replace Mr. Fox on Emblem’s board of directors. Mr. Dean’s appointment remains subject to the approval of the TSX Venture Exchange.
The Corporation thanks Mr. Fox for his significant contributions to the Corporation both as a director and previously as an executive officer of the Corporation. Mr. Fox has offered his services and help in the future as may be required on an advisory basis.
Emblem Corp. is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol “EMC” on the TSX Venture Exchange.
This news release may contain “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the use of proceeds from the Offering and the future results of operations, performance and achievements of the Corporation. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Except as required by law, the Corporation disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements. This news release contains information obtained by the Corporation from third parties and believes such information to be accurate but has not independently verified such information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information contact: